Assembly Biosciences Inc (ASMB)
14.72
-0.30
(-2.00%)
USD |
NASDAQ |
Nov 21, 16:00
14.79
+0.07
(+0.48%)
After-Hours: 20:00
Assembly Biosciences Enterprise Value: -1.389M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -1.389M |
| November 20, 2024 | 0.5176M |
| November 19, 2024 | 2.552M |
| November 18, 2024 | 5.730M |
| November 15, 2024 | 7.637M |
| November 14, 2024 | 13.42M |
| November 13, 2024 | 11.20M |
| November 12, 2024 | 10.37M |
| November 11, 2024 | 9.353M |
| November 08, 2024 | 11.70M |
| November 07, 2024 | 16.28M |
| November 06, 2024 | 10.88M |
| November 05, 2024 | 10.31M |
| November 04, 2024 | 12.98M |
| November 01, 2024 | 12.40M |
| October 31, 2024 | 11.86M |
| October 30, 2024 | 13.20M |
| October 29, 2024 | 17.58M |
| October 28, 2024 | 11.80M |
| October 25, 2024 | 12.50M |
| October 24, 2024 | 12.63M |
| October 23, 2024 | 10.53M |
| October 22, 2024 | 11.74M |
| October 21, 2024 | 10.47M |
| October 18, 2024 | 20.95M |
| Date | Value |
|---|---|
| October 17, 2024 | 20.06M |
| October 16, 2024 | 16.82M |
| October 15, 2024 | 22.73M |
| October 14, 2024 | 13.13M |
| October 11, 2024 | 15.99M |
| October 10, 2024 | 7.034M |
| October 09, 2024 | 6.716M |
| October 08, 2024 | -3.324M |
| October 07, 2024 | -1.417M |
| October 04, 2024 | -0.2734M |
| October 03, 2024 | -1.608M |
| October 02, 2024 | -1.862M |
| October 01, 2024 | -0.9724M |
| September 30, 2024 | 1.252M |
| September 27, 2024 | -9.022M |
| September 26, 2024 | -10.54M |
| September 25, 2024 | -11.88M |
| September 24, 2024 | -13.08M |
| September 23, 2024 | -6.040M |
| September 20, 2024 | 14.08M |
| September 19, 2024 | 8.175M |
| September 18, 2024 | 6.081M |
| September 17, 2024 | 6.208M |
| September 16, 2024 | 7.223M |
| September 13, 2024 | 5.446M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-78.96M
Minimum
Dec 03 2021
660.41M
Maximum
Jul 20 2020
47.04M
Average
-20.90M
Median
May 03 2023
Enterprise Value Benchmarks
| ADMA Biologics Inc | 5.050B |
| Sensus Healthcare Inc | 123.81M |
| Protagonist Therapeutics Inc | 2.014B |
| Precision BioSciences Inc | -29.06M |
| Entrada Therapeutics Inc | 226.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.613M |
| Revenue (Quarterly) | 6.845M |
| Total Expenses (Quarterly) | 17.80M |
| EPS Diluted (Quarterly) | -1.51 |
| Profit Margin (Quarterly) | -140.4% |
| Earnings Yield | -47.01% |
| Normalized Earnings Yield | -47.01 |